-
Part 1 | Session 1 Session 1.1: Next Level Structural Heart Interventions
-
Part 1 | Session 2 Session 1.2: Live Cases and Discussion
-
Part 1 | Session 4 Session 1.3: Practical Perspectives in the Context of TAVI
-
Part 1 | Session 5 Session 1.4: Live Cases and Discussions
-
Part 1 | Session 6 BREAKOUT: Current Data and Future Direction in LAAC
-
Part 2 | Session 1 Session 2.1: Strategies for Calcified Coronary Lesions Anno 2022
-
Part 2 | Session 2 Session 2.2: Live Cases and Discussion
-
Part 2 | Session 4 Session 2.3: Practical Pearls Towards a More Advanced CTO Programme
-
Part 2 | Session 5 Session 2.4: Live Cases and Discussion
-
Part 2 | Session 7 BREAKOUT: Coronary Physiology in STEMI patients today: Why? When? How?
-
Part 3 | Session 1 Session 3.1 & 3.2: Keynote & Controversies
-
Part 3 | Session 2 Session 3.3: Live Cases and Discussion
-
Part 3 | Session 4 Session 3.4: Debates
Following on from the success of 2021's inaugural edition, Transcatheter Interventions Online 2022 brings together a world-class faculty to provide expert insight and educational learning on the latest developments in interventional management.
Combining expert opinion and discussion, presentations, and live cases from centres on both sides of the Atlantic, TIO 2022 delivers best-in-class learning, supporting the latest in diagnosis, treatment strategies and patient management.
Note, the live version of this session was CME accredited; this on-demand version is not.
Key Learning Objectives
- Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
- Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
- Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
- Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
- Discuss the need for gender-specific trials and renal denervation
Target Audience
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
More from this programme
Part 1
Day One: Structural Heart Disease
Part 2
Day Two: Coronary Heart Disease: High Risk & Complex PCI
Part 3
Day Three: Debates and Controversies
Faculty Biographies
Felix Mahfoud
Professor of Cardiology and Chairman of the Department of Cardiology
Prof Felix Mahfoud is a German-born physician and cardiologist. He completed his medical studies and doctorate at Johann-Wolfgang-Goethe University in Frankfurt, Germany, graduating in 2008. Early in his career, he trained in internal medicine and cardiology at Saarland University Medical Center in Homburg, Germany, where he later served in a variety of clinical and leadership roles before relocating to Switzerland. He holds an additional academic appointment as a Visiting Professor at Harvard-MIT in Biomedical Engineering in Boston, MA. Prof Mahfoud currently lives and works in Basel, Switzerland, where he leads the Department of Cardiology at University Hospital Basel.
Academic History
Prof Mahfoud studied medicine at Goethe University Frankfurt, completing his doctorate in 2008. He undertook his residency and specialist training in internal medicine and cardiology, including intensive care and emergency medicine, at Saarland University Medical Center…
Andrew SP Sharp
Professor of Cardiology
Andrew Sharp qualified from Edinburgh Medical School in 1998 and subsequently pursued an MD postgraduate research degree at the University of Edinburgh. His doctoral research focused on the hypertensive heart, establishing a foundation for his ongoing clinical and academic interest in hypertension and cardiovascular disease.
Clinical Training & Early Career
Dr Sharp completed his early clinical training at the Royal Infirmary of Edinburgh before moving to London for senior clinical training at the hospitals of Imperial College London. He then undertook the prestigious Milan-Imperial Interventional Cardiology Fellowship programme, which included a year in Milan at San Raffaele and Columbus Hospitals, where he trained under leading experts in interventional cardiology. This combination of UK and international training shaped his expertise in complex coronary interventions and device-based therapies.
Career Progression
- In…
Roland E Schmieder
Professor of Internal Medicine, Nephrology and Hypertension, Head of the Clinical Research Centre and Vice Chair of the Department of Nephrology and Hypertension
Roland E Schmieder is a German physician-scientist whose career has been dedicated to internal medicine, nephrology, and hypertension. He has spent the majority of his professional life in Germany, where he has combined patient care, clinical research, and academic leadership at major university and community hospitals. His work has focused on the prevention and treatment of cardiovascular and renal disease, with an emphasis on hypertension and vascular risk.
Academic History
Professor Schmieder graduated in medicine from the University of Tübingen, Germany. He completed his post-graduate medical training in nephrology, cardiology, and hypertension at the University Hospital of Bonn. He later pursued advanced training at the Alton Ochsner Foundation in New Orleans, United States, where he further expanded his expertise in cardiovascular and renal medicine and clinical research.
Career Overview
Professor Schmieder is Professor of…